Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Alterity Therapeutics stock | $1.28

Learn how to easily invest in Alterity Therapeutics stock.

Alterity Therapeutics Limited is a biotechnology business based in the US. Alterity Therapeutics shares (ATHE) are listed on the NASDAQ and all prices are listed in US Dollars. Alterity Therapeutics employs 11 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Alterity Therapeutics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ATHE – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Alterity Therapeutics stock price (NASDAQ: ATHE)

Use our graph to track the performance of ATHE stocks over time.

Alterity Therapeutics shares at a glance

Information last updated 2021-10-18.
Latest market close$1.28
52-week range$1.09 - $2.48
50-day moving average $1.31
200-day moving average $1.37
Wall St. target price$4.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.42

Buy Alterity Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Alterity Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Alterity Therapeutics price performance over time

Historical closes compared with the close of $1.28 from 2021-10-21

1 week (2021-10-15) -2.29%
1 month (2021-09-22) 1.28
3 months (2021-07-22) -7.25%
6 months (2021-04-22) -12.93%
1 year (2020-10-22) -19.50%
2 years (2019-10-22) 13.27%
3 years (2018-10-22) 1.95
5 years (2016-10-21) 3.11

Alterity Therapeutics financials

Revenue TTM $4.3 million
Gross profit TTM $4 million
Return on assets TTM -46.5%
Return on equity TTM -81.39%
Profit margin 0%
Book value $0.90
Market capitalisation $57.1 million

TTM: trailing 12 months

Shorting Alterity Therapeutics shares

There are currently 740,719 Alterity Therapeutics shares held short by investors – that's known as Alterity Therapeutics's "short interest". This figure is 13% down from 851,629 last month.

There are a few different ways that this level of interest in shorting Alterity Therapeutics shares can be evaluated.

Alterity Therapeutics's "short interest ratio" (SIR)

Alterity Therapeutics's "short interest ratio" (SIR) is the quantity of Alterity Therapeutics shares currently shorted divided by the average quantity of Alterity Therapeutics shares traded daily (recently around 339779.35779817). Alterity Therapeutics's SIR currently stands at 2.18. In other words for every 100,000 Alterity Therapeutics shares traded daily on the market, roughly 2180 shares are currently held short.

However Alterity Therapeutics's short interest can also be evaluated against the total number of Alterity Therapeutics shares, or, against the total number of tradable Alterity Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Alterity Therapeutics's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Alterity Therapeutics shares in existence, roughly 20 shares are currently held short) or 0.0225% of the tradable shares (for every 100,000 tradable Alterity Therapeutics shares, roughly 23 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Alterity Therapeutics.

Find out more about how you can short Alterity Therapeutics stock.

Alterity Therapeutics share dividends

We're not expecting Alterity Therapeutics to pay a dividend over the next 12 months.

Have Alterity Therapeutics's shares ever split?

Alterity Therapeutics's shares were split on a 1:6 basis on 23 March 2016. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Alterity Therapeutics shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Alterity Therapeutics shares which in turn could have impacted Alterity Therapeutics's share price.

Alterity Therapeutics share price volatility

Over the last 12 months, Alterity Therapeutics's shares have ranged in value from as little as $1.09 up to $2.48. A popular way to gauge a stock's volatility is its "beta".

ATHE.US volatility(beta: 1.12)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Alterity Therapeutics's is 1.1199. This would suggest that Alterity Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Alterity Therapeutics overview

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase IIa clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia. .

Frequently asked questions

What percentage of Alterity Therapeutics is owned by institutions?
Currently 2.469% of Alterity Therapeutics shares are held by institutions.
How many people work for Alterity Therapeutics?
Latest data suggests 11 work at Alterity Therapeutics.
When does the fiscal year end for Alterity Therapeutics?
Alterity Therapeutics's fiscal year ends in June.
Where is Alterity Therapeutics based?
Alterity Therapeutics's address is: 460 Bourke Street, Melbourne, VIC, Australia, 3000
What is Alterity Therapeutics's ISIN number?
Alterity Therapeutics's international securities identification number is: US02155X1063
What is Alterity Therapeutics's CUSIP number?
Alterity Therapeutics's Committee on Uniform Securities Identification Procedures number is: 02155X106

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site